May 16, 2017 / 11:17 AM / 5 months ago

BRIEF-Can-Fite files clinical trial application in Canada for Piclidenoson

May 16 (Reuters) - Can Fite Biopharma Ltd

* Can-Fite files clinical trial application in canada for piclidenoson ahead of upcoming acrobat rheumatoid arthritis phase iii study

* Can fite biopharma ltd says intends to commence its phase iii acrobat trial of piclidenoson in treatment of rheumatoid arthritis in q2 of 2017

* Can fite biopharma ltd - can-fite intends to commence its phase iii acrobat trial of piclidenoson in treatment of rheumatoid arthritis in q2 of 2017. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below